Ethical aspects of renal transplantation from living donors
Identifieur interne :
000199 ( PascalFrancis/Corpus );
précédent :
000198;
suivant :
000200
Ethical aspects of renal transplantation from living donors
Auteurs : P. Bruzzone ;
P. B. BerlocoSource :
-
Transplantation proceedings [ 0041-1345 ] ; 2007.
RBID : Pascal:07-0413432
Descripteurs français
English descriptors
Abstract
Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantages for the donor other than increased self-esteem, but it at least remains an extremely safe procedure, with a worldwide overall mortality of 0.03%. This theoretical risk for the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be effectively prevented, not only for ethical but also medical reasons. The risks are too high, not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus (HIV) or other infective agents, as well as of inappropriate medical and surgical management of donors and also recipients, who are often discharged too early. Most public or private insurance companies consider kidney donation a safe procedure without long-term impairment and therefore do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our Center does not perform anonymous living organ donation or "cross-over" transplantation.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0041-1345 |
|---|
| A02 | 01 | | | @0 TRPPA8 |
|---|
| A03 | | 1 | | @0 Transplant. proc. |
|---|
| A05 | | | | @2 39 |
|---|
| A06 | | | | @2 6 |
|---|
| A08 | 01 | 1 | ENG | @1 Ethical aspects of renal transplantation from living donors |
|---|
| A09 | 01 | 1 | ENG | @1 Proceedings of the XXX Congress of the Italian Transplantation Society, November 30-December 2, 2006, Padova, Italy |
|---|
| A11 | 01 | 1 | | @1 BRUZZONE (P.) |
|---|
| A11 | 02 | 1 | | @1 BERLOCO (P. B.) |
|---|
| A12 | 01 | 1 | | @1 D'AMICO (Davide) @9 ed. |
|---|
| A12 | 02 | 1 | | @1 CILLO (Umberto) @9 ed. |
|---|
| A14 | 01 | | | @1 Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza," @2 Rome @3 ITA @Z 1 aut. @Z 2 aut. |
|---|
| A15 | 01 | | | @1 University of Padua @2 Padua @3 ITA @Z 1 aut. @Z 2 aut. |
|---|
| A18 | 01 | 1 | | @1 Italian Society of Transplantation @3 ITA @9 org-cong. |
|---|
| A20 | | | | @1 1785-1786 |
|---|
| A21 | | | | @1 2007 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 14765 @5 354000146625560130 |
|---|
| A44 | | | | @0 0000 @1 © 2007 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 8 ref. |
|---|
| A47 | 01 | 1 | | @0 07-0413432 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Transplantation proceedings |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C01 | 01 | | ENG | @0 Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantages for the donor other than increased self-esteem, but it at least remains an extremely safe procedure, with a worldwide overall mortality of 0.03%. This theoretical risk for the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be effectively prevented, not only for ethical but also medical reasons. The risks are too high, not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus (HIV) or other infective agents, as well as of inappropriate medical and surgical management of donors and also recipients, who are often discharged too early. Most public or private insurance companies consider kidney donation a safe procedure without long-term impairment and therefore do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our Center does not perform anonymous living organ donation or "cross-over" transplantation. |
|---|
| C02 | 01 | X | | @0 002B25H |
|---|
| C02 | 02 | X | | @0 002A06F |
|---|
| C02 | 03 | X | | @0 002B31 |
|---|
| C03 | 01 | X | FRE | @0 Homotransplantation @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Homotransplantation @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Homotrasplante @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Ethique @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Ethics @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Etica @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Santé publique @5 03 |
|---|
| C03 | 03 | X | ENG | @0 Public health @5 03 |
|---|
| C03 | 03 | X | SPA | @0 Salud pública @5 03 |
|---|
| C03 | 04 | X | FRE | @0 Rein @5 05 |
|---|
| C03 | 04 | X | ENG | @0 Kidney @5 05 |
|---|
| C03 | 04 | X | SPA | @0 Riñón @5 05 |
|---|
| C03 | 05 | X | FRE | @0 Donneur vivant @5 06 |
|---|
| C03 | 05 | X | ENG | @0 Living donor @5 06 |
|---|
| C03 | 05 | X | SPA | @0 Donador vivo @5 06 |
|---|
| C03 | 06 | X | FRE | @0 Médecine @5 08 |
|---|
| C03 | 06 | X | ENG | @0 Medicine @5 08 |
|---|
| C03 | 06 | X | SPA | @0 Medicina @5 08 |
|---|
| C03 | 07 | X | FRE | @0 Greffe @5 25 |
|---|
| C03 | 07 | X | ENG | @0 Graft @5 25 |
|---|
| C03 | 07 | X | SPA | @0 Injerto @5 25 |
|---|
| C03 | 08 | X | FRE | @0 Traitement @5 26 |
|---|
| C03 | 08 | X | ENG | @0 Treatment @5 26 |
|---|
| C03 | 08 | X | SPA | @0 Tratamiento @5 26 |
|---|
| C03 | 09 | X | FRE | @0 Transplantation rénale @4 CD @5 96 |
|---|
| C03 | 09 | X | ENG | @0 Kidney transplantation @4 CD @5 96 |
|---|
| C03 | 09 | X | SPA | @0 Trasplante de riñón @4 CD @5 96 |
|---|
| C07 | 01 | X | FRE | @0 Appareil urinaire @5 37 |
|---|
| C07 | 01 | X | ENG | @0 Urinary system @5 37 |
|---|
| C07 | 01 | X | SPA | @0 Aparato urinario @5 37 |
|---|
| C07 | 02 | X | FRE | @0 Chirurgie @5 38 |
|---|
| C07 | 02 | X | ENG | @0 Surgery @5 38 |
|---|
| C07 | 02 | X | SPA | @0 Cirugía @5 38 |
|---|
| N21 | | | | @1 267 |
|---|
| N44 | 01 | | | @1 OTO |
|---|
| N82 | | | | @1 OTO |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 Congress of the Italian Society of Transplantation @2 30 @3 Padova ITA @4 2006-11-30 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 07-0413432 INIST |
|---|
| ET : | Ethical aspects of renal transplantation from living donors |
|---|
| AU : | BRUZZONE (P.); BERLOCO (P. B.); D'AMICO (Davide); CILLO (Umberto) |
|---|
| AF : | Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"/Rome/Italie (1 aut., 2 aut.); University of Padua/Padua/Italie (1 aut., 2 aut.) |
|---|
| DT : | Publication en série; Congrès; Niveau analytique |
|---|
| SO : | Transplantation proceedings; ISSN 0041-1345; Coden TRPPA8; Etats-Unis; Da. 2007; Vol. 39; No. 6; Pp. 1785-1786; Bibl. 8 ref. |
|---|
| LA : | Anglais |
|---|
| EA : | Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantages for the donor other than increased self-esteem, but it at least remains an extremely safe procedure, with a worldwide overall mortality of 0.03%. This theoretical risk for the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be effectively prevented, not only for ethical but also medical reasons. The risks are too high, not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus (HIV) or other infective agents, as well as of inappropriate medical and surgical management of donors and also recipients, who are often discharged too early. Most public or private insurance companies consider kidney donation a safe procedure without long-term impairment and therefore do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our Center does not perform anonymous living organ donation or "cross-over" transplantation. |
|---|
| CC : | 002B25H; 002A06F; 002B31 |
|---|
| FD : | Homotransplantation; Ethique; Santé publique; Rein; Donneur vivant; Médecine; Greffe; Traitement; Transplantation rénale |
|---|
| FG : | Appareil urinaire; Chirurgie |
|---|
| ED : | Homotransplantation; Ethics; Public health; Kidney; Living donor; Medicine; Graft; Treatment; Kidney transplantation |
|---|
| EG : | Urinary system; Surgery |
|---|
| SD : | Homotrasplante; Etica; Salud pública; Riñón; Donador vivo; Medicina; Injerto; Tratamiento; Trasplante de riñón |
|---|
| LO : | INIST-14765.354000146625560130 |
|---|
| ID : | 07-0413432 |
|---|
Links to Exploration step
Pascal:07-0413432
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ethical aspects of renal transplantation from living donors</title>
<author><name sortKey="Bruzzone, P" sort="Bruzzone, P" uniqKey="Bruzzone P" first="P." last="Bruzzone">P. Bruzzone</name>
<affiliation><inist:fA14 i1="01"><s1>Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><author><name sortKey="Berloco, P B" sort="Berloco, P B" uniqKey="Berloco P" first="P. B." last="Berloco">P. B. Berloco</name>
<affiliation><inist:fA14 i1="01"><s1>Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0413432</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0413432 INIST</idno>
<idno type="RBID">Pascal:07-0413432</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000199</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ethical aspects of renal transplantation from living donors</title>
<author><name sortKey="Bruzzone, P" sort="Bruzzone, P" uniqKey="Bruzzone P" first="P." last="Bruzzone">P. Bruzzone</name>
<affiliation><inist:fA14 i1="01"><s1>Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><author><name sortKey="Berloco, P B" sort="Berloco, P B" uniqKey="Berloco P" first="P. B." last="Berloco">P. B. Berloco</name>
<affiliation><inist:fA14 i1="01"><s1>Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14><series><title level="j" type="main">Transplantation proceedings</title>
<title level="j" type="abbreviated">Transplant. proc.</title>
<idno type="ISSN">0041-1345</idno>
<imprint><date when="2007">2007</date>
</imprint><seriesStmt><title level="j" type="main">Transplantation proceedings</title>
<title level="j" type="abbreviated">Transplant. proc.</title>
<idno type="ISSN">0041-1345</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ethics</term>
<term>Graft</term>
<term>Homotransplantation</term>
<term>Kidney</term>
<term>Kidney transplantation</term>
<term>Living donor</term>
<term>Medicine</term>
<term>Public health</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Homotransplantation</term>
<term>Ethique</term>
<term>Santé publique</term>
<term>Rein</term>
<term>Donneur vivant</term>
<term>Médecine</term>
<term>Greffe</term>
<term>Traitement</term>
<term>Transplantation rénale</term>
</keywords><front><div type="abstract" xml:lang="en">Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantages for the donor other than increased self-esteem, but it at least remains an extremely safe procedure, with a worldwide overall mortality of 0.03%. This theoretical risk for the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be effectively prevented, not only for ethical but also medical reasons. The risks are too high, not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus (HIV) or other infective agents, as well as of inappropriate medical and surgical management of donors and also recipients, who are often discharged too early. Most public or private insurance companies consider kidney donation a safe procedure without long-term impairment and therefore do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our Center does not perform anonymous living organ donation or "cross-over" transplantation.</div>
</front><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0041-1345</s0>
</fA01><fA02 i1="01"><s0>TRPPA8</s0>
</fA02><fA03 i2="1"><s0>Transplant. proc.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Ethical aspects of renal transplantation from living donors</s1>
</fA08><fA09 i1="01" i2="1" l="ENG"><s1>Proceedings of the XXX Congress of the Italian Transplantation Society, November 30-December 2, 2006, Padova, Italy</s1>
</fA09><fA11 i1="01" i2="1"><s1>BRUZZONE (P.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>BERLOCO (P. B.)</s1>
</fA11><fA12 i1="01" i2="1"><s1>D'AMICO (Davide)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="02" i2="1"><s1>CILLO (Umberto)</s1>
<s9>ed.</s9>
</fA12><fA14 i1="01"><s1>Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14><fA15 i1="01"><s1>University of Padua</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15><fA18 i1="01" i2="1"><s1>Italian Society of Transplantation</s1>
<s3>ITA</s3>
<s9>org-cong.</s9>
</fA18><fA20><s1>1785-1786</s1>
</fA20><fA21><s1>2007</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>14765</s2>
<s5>354000146625560130</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>8 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>07-0413432</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i1="01" i2="1"><s0>Transplantation proceedings</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC01 i1="01" l="ENG"><s0>Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantages for the donor other than increased self-esteem, but it at least remains an extremely safe procedure, with a worldwide overall mortality of 0.03%. This theoretical risk for the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be effectively prevented, not only for ethical but also medical reasons. The risks are too high, not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus (HIV) or other infective agents, as well as of inappropriate medical and surgical management of donors and also recipients, who are often discharged too early. Most public or private insurance companies consider kidney donation a safe procedure without long-term impairment and therefore do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our Center does not perform anonymous living organ donation or "cross-over" transplantation.</s0>
</fC01><fC02 i1="01" i2="X"><s0>002B25H</s0>
</fC02><fC02 i1="02" i2="X"><s0>002A06F</s0>
</fC02><fC02 i1="03" i2="X"><s0>002B31</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Homotransplantation</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Homotransplantation</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Homotrasplante</s0>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Ethique</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Ethics</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Etica</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Public health</s0>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>03</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Rein</s0>
<s5>05</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Kidney</s0>
<s5>05</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Riñón</s0>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Donneur vivant</s0>
<s5>06</s5>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Living donor</s0>
<s5>06</s5>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Donador vivo</s0>
<s5>06</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Médecine</s0>
<s5>08</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Medicine</s0>
<s5>08</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Medicina</s0>
<s5>08</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Greffe</s0>
<s5>25</s5>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Graft</s0>
<s5>25</s5>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Injerto</s0>
<s5>25</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Traitement</s0>
<s5>26</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Treatment</s0>
<s5>26</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>26</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Transplantation rénale</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Kidney transplantation</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Trasplante de riñón</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Appareil urinaire</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Urinary system</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Aparato urinario</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Chirurgie</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Surgery</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Cirugía</s0>
<s5>38</s5>
</fC07><fN21><s1>267</s1>
</fN21><fN44 i1="01"><s1>OTO</s1>
</fN44><fN82><s1>OTO</s1>
</fN82><pR><fA30 i1="01" i2="1" l="ENG"><s1>Congress of the Italian Society of Transplantation</s1>
<s2>30</s2>
<s3>Padova ITA</s3>
<s4>2006-11-30</s4>
</fA30><server><NO>PASCAL 07-0413432 INIST</NO>
<ET>Ethical aspects of renal transplantation from living donors</ET>
<AU>BRUZZONE (P.); BERLOCO (P. B.); D'AMICO (Davide); CILLO (Umberto)</AU>
<AF>Divisione Trapianti d'Organo, Dipartimento "Paride Stefanini," Università di Roma "La Sapienza,"/Rome/Italie (1 aut., 2 aut.); University of Padua/Padua/Italie (1 aut., 2 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Transplantation proceedings; ISSN 0041-1345; Coden TRPPA8; Etats-Unis; Da. 2007; Vol. 39; No. 6; Pp. 1785-1786; Bibl. 8 ref.</SO>
<LA>Anglais</LA>
<EA>Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantages for the donor other than increased self-esteem, but it at least remains an extremely safe procedure, with a worldwide overall mortality of 0.03%. This theoretical risk for the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be effectively prevented, not only for ethical but also medical reasons. The risks are too high, not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus (HIV) or other infective agents, as well as of inappropriate medical and surgical management of donors and also recipients, who are often discharged too early. Most public or private insurance companies consider kidney donation a safe procedure without long-term impairment and therefore do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our Center does not perform anonymous living organ donation or "cross-over" transplantation.</EA>
<CC>002B25H; 002A06F; 002B31</CC>
<FD>Homotransplantation; Ethique; Santé publique; Rein; Donneur vivant; Médecine; Greffe; Traitement; Transplantation rénale</FD>
<FG>Appareil urinaire; Chirurgie</FG>
<ED>Homotransplantation; Ethics; Public health; Kidney; Living donor; Medicine; Graft; Treatment; Kidney transplantation</ED>
<EG>Urinary system; Surgery</EG>
<SD>Homotrasplante; Etica; Salud pública; Riñón; Donador vivo; Medicina; Injerto; Tratamiento; Trasplante de riñón</SD>
<LO>INIST-14765.354000146625560130</LO>
<ID>07-0413432</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000199 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000199 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:07-0413432
|texte= Ethical aspects of renal transplantation from living donors
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021 |  |
